Abstract
A case of abnormal biodistribution of a bone scanning radiopharmaceutical due to iron dextran therapy is presented, and possible mechanisms are discussed.
Original language | English |
---|---|
Pages (from-to) | 818-820 |
Number of pages | 3 |
Journal | Clinical Nuclear Medicine |
Volume | 15 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1990 |
Externally published | Yes |
ASJC Scopus Subject Areas
- Radiology Nuclear Medicine and imaging